MedSciences Capital
7
8M
6
0.47
1
0.14
2
- Areas of investment
Summary
MedSciences Capital is the famous VC, which was founded in 2006. The venture was found in Europe in The Netherlands. The leading representative office of defined VC is situated in the Amsterdam.
Among the most popular portfolio startups of the fund, we may highlight Kiadis Pharma, Mucosis, Pronota. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Therapeutics.
Opposing the other organizations, this MedSciences Capital works on 14 percentage points more the average amount of lead investments. The top activity for fund was in 2007. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2015. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the MedSciences Capital, startups are often financed by Life Sciences Partners, Idinvest Partners, Gimv. The meaningful sponsors for the fund in investment in the same round are NV NOM, Life Sciences Partners, BioGeneration Ventures. In the next rounds fund is usually obtained by Life Sciences Partners, Kreos Capital, BioGeneration Ventures.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.47
- Follow on index
- 0.14
- Investments by industry
- Health Care (6)
- Biotechnology (5)
- Medical (5)
- Biopharma (1)
- Pharmaceutical (1) Show 4 more
- Investments by region
-
- Netherlands (5)
- The Netherlands (1)
- Belgium (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 140M
- Group Appearance index
- 0.86
- Avg. company exit year
- 12
- Avg. multiplicator
- 21.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Net Medical | 01 Jan 2011 | Health Care, Medical | Seed | 0 | The Netherlands, Utrecht, Netherlands |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.